Co-Authors
This is a "connection" page, showing publications co-authored by Juthathip Mongkolsapaya and Gavin Screaton.
Connection Strength
3.987
-
Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Challenges of a Dengue Vaccine. Cold Spring Harb Perspect Biol. 2018 06 01; 10(6).
Score: 0.770
-
Evolution of neurovirulent Zika virus. Science. 2017 11 17; 358(6365):863-864.
Score: 0.742
-
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Cell. 2021 08 05; 184(16):4220-4236.e13.
Score: 0.238
-
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell. 2021 04 29; 184(9):2348-2361.e6.
Score: 0.233
-
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera. Cell. 2021 04 15; 184(8):2201-2211.e7.
Score: 0.233
-
The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021 04 15; 184(8):2183-2200.e22.
Score: 0.233
-
The immune response against flaviviruses. Nat Immunol. 2018 11; 19(11):1189-1198.
Score: 0.198
-
Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response. Nat Immunol. 2017 Nov; 18(11):1228-1237.
Score: 0.184
-
The immunopathology of dengue and Zika virus infections. Curr Opin Immunol. 2017 10; 48:1-6.
Score: 0.181
-
Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope. Nat Commun. 2017 05 23; 8:15411.
Score: 0.179
-
Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol. 2015 May; 16(5):544.
Score: 0.156
-
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine. ACS Cent Sci. 2021 Apr 28; 7(4):594-602.
Score: 0.059
-
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2. Nat Commun. 2021 03 29; 12(1):1951.
Score: 0.059
-
Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels. Transfus Med. 2021 Jun; 31(3):167-175.
Score: 0.057
-
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020. Euro Surveill. 2020 10; 25(42).
Score: 0.057
-
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. Cell Host Microbe. 2020 09 09; 28(3):497.
Score: 0.056
-
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat Immunol. 2020 11; 21(11):1336-1345.
Score: 0.056
-
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. Nat Struct Mol Biol. 2020 10; 27(10):950-958.
Score: 0.056
-
SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. Wellcome Open Res. 2020; 5:181.
Score: 0.056
-
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. Cell Host Microbe. 2020 09 09; 28(3):445-454.e6.
Score: 0.055
-
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel. Wellcome Open Res. 2020; 5:139.
Score: 0.055
-
Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine. J Virol. 2018 12 01; 92(23).
Score: 0.050
-
T cell responses to whole SARS coronavirus in humans. J Immunol. 2008 Oct 15; 181(8):5490-500.
Score: 0.025